Here are four notes:
1. The new drug interferes with a toxin that C. diff creates.
2. Tests in mice suggest it can stop C. diff from damaging the inside of the intestine.
3. The lead compound in the drug is ebselen, which has been tested in humans.
4. The drug is not an antibiotic and can be taken as a pill.
More articles on GI/endoscopy:
FDA clears 6 GI/endoscopy devices in August
10 of the biggest GI/endoscopy stories in 2015
5 recent GI study findings to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.